// App-Quantinova.ai

: Belumosudil Combination Therapy in Refractory Chronic Graft-Versus-Host Disease

Researchers

Presenter

  • Michelle Chin

Principal Investigators

  • Judith A. Shizuru

  • Lori Muffly

  • Parveen Shiraz

  • Laura J. Johnston

  • Robert Lowsky

  • Andrew R. Rezvani

  • Matthew J. Frank

  • Sushma Bharadwaj

  • Wen-Kai Weng

  • Robert S. Negrin

  • David B. Miklos

  • Sally Arai

Medical Centers

  • Division of BMT and Cellular Therapy, Stanford University, Stanford, CA

  • University of Central Florida College of Medicine, Orlando

  • Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University School of Medicine, Palo Alto, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Autoimmune (AI)

Disease

  • Graft-versus-host disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Ruxolitinib phosphate

  • Ibrutinib

  • sirolimus

  • Rapacan

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved